Decompensated Heart Failure Clinical Trial
Official title:
Optimizing Treatments for Heart Failure During Hospitalization
Heart failure reaches 1.5 million people in France and is responsible for 200,000 hospitalizations per year. Over the past ten years, new therapies have emerged (treatment of martial deficiency, Entresto, iSGLT2). Hospitalization in a context of acute heart failure is a moment of choice in the history of the disease to introduce recommended treatments under closer supervision (clinical, biological) than in ambulatory, and allows a decrease in hospitalizations, morbidity and mortality. The purpose of this study is to describe the introduction of heart failure drugs (including iSGLT2) in real-life settings in patients hospitalized for decompensated heart failure.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Terminated |
NCT00355017 -
BNP Guided Care in Addition to Multidisciplinary Care
|
N/A | |
| Active, not recruiting |
NCT03701880 -
Early Use of Ivabradine in Heart Failure
|
N/A | |
| Recruiting |
NCT03157219 -
Manipal Heart Failure Registry (MHFR)
|
N/A | |
| Recruiting |
NCT06114498 -
Hospital Register of Decompensated Heart Failure With Preserved Ejection Fraction
|
||
| Completed |
NCT03838003 -
Exercise in Patients Admitted With Recently Decompensated Heart Failure
|
N/A | |
| Completed |
NCT02997462 -
Monocyte Phenotypic Changes in Heart Failure
|
||
| Completed |
NCT04493346 -
Shear Wave Elastography
|
||
| Recruiting |
NCT02666651 -
Regional Tolvaptan Registry
|
Phase 4 | |
| Recruiting |
NCT02236247 -
Control of Sinus Node Tachycardia as an Additional Therapy in Patients With Decompensated Heart Failure
|
Phase 1/Phase 2 | |
| Not yet recruiting |
NCT06273397 -
Acetazolamide or Metolazone in Acute Heart Failure
|
N/A | |
| Completed |
NCT05927285 -
Effect on Kidney Function Recovery Guiding Decongestion With VExUS in Patients With Cardiorenal Syndrome 1
|
N/A | |
| Withdrawn |
NCT04572867 -
Aquapheresis Efficacy in Outpatients With Decompensated Heart Failure
|
N/A | |
| Completed |
NCT02157506 -
A Dose Ranging Phase IIa Study of 6 Hour Intravenous Dosages of CXL-1427 in Patients Hospitalized With Heart Failure
|
Phase 2 | |
| Recruiting |
NCT03914222 -
Comparing PA Compliance During and After Decompensation in HFP
|
N/A | |
| Recruiting |
NCT06286423 -
Colchicine in Acutely Decompensated HFREF
|
Phase 4 | |
| Recruiting |
NCT03009552 -
Speckle Tracking Echocardiography Adds Information in Decompensated Heart Failure
|
N/A | |
| Completed |
NCT04019314 -
Assessment of ProEnkephalin to Detect Acute Kidney Injury (AKI)
|
N/A | |
| Recruiting |
NCT02649517 -
Clinical and Morphological Characteristics of Chronic Inflammation in the Myocardium in Patients With Decompensated HF With Ischemic Systolic Dysfunction
|
N/A | |
| Recruiting |
NCT03440970 -
Mechanism and Effects of Manipulating Chloride Homeostasis in Stable Heart Failure
|
Early Phase 1 | |
| Recruiting |
NCT05090930 -
Innovative Technologies for the Treatment of Pulmonary and Heart Failure
|
N/A |